Arteris, Inc. $AIP Shares Sold by Eventide Asset Management LLC

Key Points

• Eventide Asset Management LLC reduced its holdings in Arteris, Inc. by 12.1%, now owning approximately 0.67% of the company, valued at $1.93 million.
• Insider trading activity saw the COO Laurent R. Moll and director Saiyed Atiq Raza each selling a significant number of shares, indicating a 9.66% decrease in their positions.
• Analysts are optimistic about Arteris, with several maintaining a buy rating and an average price target of $15.00, following an upward revision from TD Cowen.

Eventide Asset Management LLC reduced its position in Arteris, Inc. (NASDAQ:AIP - Free Report) by 12.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 279,095 shares of the company's stock after selling 38,530 shares during the period. Eventide Asset Management LLC owned about 0.67% of Arteris worth $1,929,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also modified their holdings of the company. GAMMA Investing LLC grew its position in shares of Arteris by 11,823.3% during the 1st quarter. GAMMA Investing LLC now owns 5,127 shares of the company's stock valued at $350,000 after acquiring an additional 5,084 shares during the period. CWM LLC raised its stake in shares of Arteris by 4,810.1% during the 1st quarter. CWM LLC now owns 10,213 shares of the company's stock worth $71,000 after buying an additional 10,005 shares during the period. D. E. Shaw & Co. Inc. purchased a new position in shares of Arteris during the 4th quarter valued at approximately $110,000. Price T Rowe Associates Inc. MD acquired a new stake in Arteris in the 4th quarter valued at $117,000. Finally, Wells Fargo & Company MN increased its holdings in Arteris by 38.9% in the 4th quarter. Wells Fargo & Company MN now owns 13,192 shares of the company's stock worth $134,000 after acquiring an additional 3,694 shares in the last quarter. Institutional investors and hedge funds own 64.36% of the company's stock.

Arteris Price Performance

NASDAQ AIP traded up $0.13 during trading hours on Tuesday, hitting $8.72. 505,878 shares of the company's stock traded hands, compared to its average volume of 550,269. The company has a market capitalization of $371.91 million, a PE ratio of -10.63 and a beta of 1.44. Arteris, Inc. has a 52-week low of $5.46 and a 52-week high of $14.29. The firm's 50-day moving average is $9.51 and its 200-day moving average is $8.21.

Arteris (NASDAQ:AIP - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share for the quarter, hitting the consensus estimate of ($0.11). The business had revenue of $16.50 million for the quarter, compared to analysts' expectations of $16.35 million. Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities research analysts predict that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Arteris news, COO Laurent R. Moll sold 42,692 shares of the company's stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $8.94, for a total value of $381,666.48. Following the completion of the sale, the chief operating officer directly owned 399,379 shares in the company, valued at $3,570,448.26. This represents a 9.66% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Bayview Legacy, Llc sold 50,000 shares of the firm's stock in a transaction on Tuesday, August 5th. The stock was sold at an average price of $13.12, for a total value of $656,000.00. Following the completion of the sale, the insider directly owned 9,839,071 shares of the company's stock, valued at $129,088,611.52. This trade represents a 0.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 491,276 shares of company stock worth $5,810,565. 33.70% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on AIP. Rosenblatt Securities reiterated a "buy" rating and issued a $14.00 target price on shares of Arteris in a research report on Wednesday, May 21st. TD Cowen raised their price target on shares of Arteris from $12.00 to $15.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. Finally, Wall Street Zen lowered Arteris from a "hold" rating to a "sell" rating in a research note on Sunday. Three analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $15.00.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.